Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues ...

HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

Ganda campuran Indonesia Jafar Hidayatullah (kanan)/Felisha Alberta Nathaniel Pasaribu (kiri) saat melakoni babak pertama Super 750 Singapore Open 2025 menghadapi pasangan Taiwan Ming Che Lu/Hung ...

Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, attorneys general from four pro-choice states have fired back, filing (PDF ...

Presented by Alliance for Pharmacy Compounding — The Food and Drug Administration commissioner has committed to reviewing the abortion drug mifepristone after previously stating he had no plans ...

JAKARTA, KOMPAS.com - Presiden Perancis Emmanuel Macron tiba di Jakarta pada Selasa (27/5/2025) malam, memulai lawatan resmi ke Indonesia yang menjadi bagian dari tur tiga negara di Asia Tenggara..

Indonesia menyatakan dukungan penuh terhadap penyelenggaraan ASEAN AI Malaysia Summit 2025 yang akan digelar Agustus mendatang. Forum ini dinilai krusial dalam memperkuat tata kelola kecerdasan ...

Health and Human Services Secretary Robert Kennedy Jr. asked the FDA last month to review mifepristone. FDA Commissioner Marty Makary said he would do so, in correspondence released on June 2 ...

Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in medication abortions.

As state and federal officials have recently signaled a desire to restrict access to mifepristone — a drug used for abortion — some Idahoan residents and physicians are concerned about ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has ordered a fresh safety review of mifepristone, a drug commonly used in medication abortions. He asked Dr. Marty Makary ...

The study was based on insurance claims for 865,727 mifepristone abortions between 2017 and 2023. "I'm calling on the FDA to reinstate safety regulations on the chemical abortion drug immediately.